References

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

10.1016/s0360-3016(99)00183-2 · 1999 · External reference

Radiation dose-volume effects in the lung

10.1016/j.ijrobp.2009.06.091 · 2010 · External reference

Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial

10.1200/jco.2016.69.1378 · 2017 · External reference

Evaluating which dose-function metrics are most critical for functional-guided radiation therapy

10.1016/j.ijrobp.2017.03.051 · 2017 · External reference

Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes

10.1016/j.ijrobp.2013.01.004 · 2013 · External reference

A phase 2 randomized clinical trial evaluating 4DCT ventilation-based functional lung avoidance radiotherapy for non-small cell lung Cancer

10.1016/j.ijrobp.2024.02.019 · 2024 · External reference

Results of a multi-institutional phase 2 clinical trial for 4DCT-ventilation functional avoidance thoracic radiation therapy

10.1016/j.ijrobp.2021.10.147 · 2022 · External reference

Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients

10.1016/j.radonc.2023.109553 · 2023 · External reference

Functional lung avoidance and response-adaptive escalation (FLARE) RT: multimodality plan dosimetry of a precision radiation oncology strategy

10.1002/mp.12308 · 2017 · External reference

Functional lung avoidance for individualized radiation therapy: results of a double-masked, randomized controlled trial

10.1016/j.ijrobp.2022.04.047 · 2022 · External reference

Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer

10.1097/coc.0b013e318209ab93 · 2012 · External reference

Evaluating the toxicity reduction with computed tomographic ventilation functional avoidance radiation therapy

10.1016/j.ijrobp.2017.04.024 · 2017 · External reference

Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: a prospective study

10.1016/j.radonc.2015.08.005 · 2015 · External reference

Prediction of acute radiation-induced lung toxicity after stereotactic body radiation therapy using dose-volume parameters from functional mapping on gallium 68 perfusion positron emission tomography/computed tomography

10.1016/j.ijrobp.2023.10.004 · 2024 · External reference

Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? A systematic review

10.1016/j.clon.2022.01.043 · 2022 · External reference

Investigating the SPECT dose-function metrics associated with radiation-induced lung toxicity risk in patients with non-small cell lung cancer undergoing radiation therapy

2021 · External reference

Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients

10.1371/journal.pone.0204721 · 2018 · External reference

Association of artificial intelligence-screened interstitial lung disease with radiation pneumonitis in locally advanced non-small cell lung cancer

10.1016/j.radonc.2025.111144 · 2025 · External reference

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression

10.1038/nm.2971 · 2012 · External reference

Parametric response mapping as an imaging biomarker in lung transplant recipients

10.1164/rccm.201604-0732oc · 2017 · External reference

Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

10.1016/j.bbmt.2014.06.014 · 2014 · External reference

Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers

10.1016/j.acra.2018.05.024 · 2019 · External reference

Machine learning algorithms to differentiate among pulmonary complications after hematopoietic cell transplant

10.1016/j.chest.2020.02.076 · 2020 · External reference

Investigating the incidence of pulmonary abnormalities as identified by parametric response mapping in patients with lung Cancer before radiation treatment

2022 · External reference

Interstitial lung disease and risk of lung cancer

10.1001/jamanetworkopen.2025.19630 · 2025 · External reference

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history

10.1183/09031936.00144208 · 2009 · External reference

Lung cancer and interstitial lung disease: a literature review

10.21037/jtd.2018.05.75 · 2018 · External reference

Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage III non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy

10.7150/jca.24936 · 2018 · External reference

Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy

10.1186/s13014-018-1030-1 · 2018 · External reference

Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities

10.1093/jjco/hyz016 · 2019 · External reference

Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease

10.1016/j.radonc.2023.110053 · 2024 · External reference

Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study

10.1016/s2589-7500(22)00232-1 · 2023 · External reference